Physicians' desk reference. 49th ed.Montvale, NJ: Medical Economics Data Production, 1995:475, 1021,1960,2292.
2.
National Asthma Education Program Expert Panel report: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, publication no. 91–3042, 1991.
3.
International consensus report on diagnosis and management of asthma. Bethesda, MD: Department of Health and Human Services, publication no. 92–3091, 1992.
4.
TinkelmanDG, ReedCE, NelsonHS, OffordKP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics1993; 92: 64–77.
5.
CrowleyS, HindmarshPC, MatthewsDR, BrookCGD. Growth and the growth hormone axis in prepubertal children with asthma. J Pediatr1995; 126: 297–303.
6.
DoullIJM, FreezerNJ, HolgateST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med1995; 151: 1715–9.
HeuckC, WolthersOD. Knemometric assessment of short term growth in adolescents treated with inhaled budesonide. Eur Respir J1994; 7(suppl 18):449s.
9.
WolthersOD, PedersenS.Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics1992; 89: 839–42.
10.
WolthersOD, PedersenS.Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ1991; 303: 163–5.
11.
PriftisK, EverardML, MilnerAD. Unexpected side effects of inhaled steroids: a case report. Eur J Pediatr1991; 150: 448–9.
12.
WalesJKH, BarnesND, SwiftPGF. Growth retardation in children on steroids for asthma (letter). Lancet1991; 338: 1535.
13.
HollmanGA, AllenDB. Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics1988; 81: 452–5.
14.
ThomasBC, StanhopeR, GrantDB. Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids. Acta Paediatr1994; 83: 196–9.
15.
MeeranK, HattersleyA, BurrinJ, ShinerR, IbbertsonK.Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. Am J Respir Crit Care Med1995; 151: 333–6.
16.
IpM, LamK, YamL, KungA, NgM.Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest1994; 105: 1722–7.
17.
ToogoodJH, JenningsB, HodsmanAB, BaskervilleJ, FraherLJ. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol1991; 88: 572–80.
18.
AliNU, CapewellS, WardMJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax1991; 46: 160–4.
SorvaR, TurpeinenM, Juntunen-BackmanK, KaronenSL, SorvaA.Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol1992; 90: 808–15.
22.
TeelucksinghS, PadfieldPL, TibiL, GoughKJ, HoltPR. Inhaled corticosteroids, bone formation and osteocalcin. Lancet1991; 338: 60–1.
23.
LeechJA, HodderRV, OoiDS, GayJ.Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am Rev Respir Dis1993; 148: 113–5.
24.
ToogoodJH, CrillyRG, JonesG, NadeauJ, WellsGA. Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. Am Rev Respir Dis1988; 138: 57–61.
25.
PackeGE, DouglasJG, McDonaldAF, RobinsSP, ReidDM. Bone density in asthmatic patients taking high dose inhaled beclomethasone and intermittent systemic corticosteroids. Thorax1992; 47: 414–7.
26.
ReidDM, NicollJJ, SmithMA, HigginsB, TothillP, NukiG.Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J1986; 293: 1463–6.
27.
CromptonGK. Corticosteroids and bone mass in asthma (letter). Br Med J1987; 294: 123.
